Summary: NPR features a special report on MDMA research, highlighting an interview with Brenda, a woman who overcame chronic, treatment-resistant posttraumatic stress disorder (PTSD) after receiving MDMA-assisted psychotherapy in MAPS’ ongoing clinical trial in Boulder, Colorado. Brenda shares how her life and relationships have changed after she received MDMA-assisted psychotherapy, and journalist Kelley McMillan speaks about what she learned during her investigative report on MDMA research. “Now, life is good. Spending 35+ years suicidal was something I don’t wish on anyone. After 6 months in that study, I am not suicidal. I want to live,” explains Brenda.
Originally appearing here.
MDMA, often known as Ecstasy or Molly, has for decades been used as a party drug — consumed in clubs, fuel for all-night raves. But lately, the substance is also being used in very different settings, for a very different purpose: to treat post-traumatic stress disorder.
The Food and Drug Administration has approved phase two clinical studies of the treatment, and they’re now underway in four locations. Results so far have been promising, according to reporter Kelley McMillan, who has been investigating this new use of MDMA and has written about it in the current issue of Marie Claire.
“The findings from these most recent studies are supporting the earlier phase two findings, which found that 83 percent of participants were cured of their PTSD — compared to 25 percent who were cured from talk therapy alone,” she tells NPR’s Rachel Martin.
These conclusions remain preliminary, however, and phase two trials often fail by the time they reach phase three. And McMillan offers a word of caution of her own.
“People should not be going out and taking MDMA recreationally and thinking that they’re going to have these healing experiences,” she says.
Still, some therapists are hopeful about the ways they’ve seen the substance help patients who are grappling with PTSD. “One of the psychiatrists I spoke to likened it to mental anesthesia, and she said that … it allows a person to kind of get right in and get to the malignant thing that needs to be examined.”
She talks to Martin about MDMA’s physical effects and its spotty history — and they’re both joined in the conversation by Brenda, one of the patients profiled in McMillan’s story. Only Brenda’s first name has been used, for privacy reasons.
On the effect MDMA can have on the brain
McMillan: Basically, MDMA unleashes a massive release of serotonin, dopamine and oxytocin. And this creates a state in which participants are very calm, and there’s a deep feeling of trust with their therapist. So they’re able to explore their trauma and process it.
On how this drug came to be used to treat PTSD in the first place
McMillan: Well, this is what I found so fascinating. Really in fact, MDMA was first used in the ’70s and early ’80s in therapy, in an underground network of therapists — but it wasn’t illegal yet.
And then it got coopted by clubbers in the ’80s, so consequently MDMA has gotten a really bad rap and has been sort of the subject of a really unfair publicity campaign.
Brenda, on how MDMA has affected her therapy
Brenda: As a child, I was abused and tortured by my father from the time I was 3 until I was 12. And as an adult, I saw a therapist every single week for 15 years — and I still wanted to die. You know, I was suicidal since I was 5 because that was the only way that I thought I could find [a] solution.
Two years ago, I had a colleague who said, “Hey, I’ve got my wife who has been struggling with PTSD as well. She’s seeing this great therapist that’s doing a little bit different kind of therapy, trying to process trauma through the body. You might try that” So I went, very skeptically.
And about six months into therapy, I take the medicine from my doctor, and within about an hour, I had a lot of imagery come up for me — some people do. And the first place I saw was this maze. It looked like a maze that I had been to as a kid, and I remember thinking very clearly, “All right, here we go” — and went in. And, yes, there was so much trauma. I had never remembered these terrible, terrible things.
And before MDMA, I really did think it was my fault. I mean, I felt it in my bones that something was so wrong with me, that I deserved those things. And being on the MDMA was the first time I’d ever felt compassion for myself, realizing that I was a child, I had no choice. I had no choice.
On what life is like for Brenda now
Brenda: It’s like I’ve been living life with the mute button on. You know, before the MDMA study, I could see what was happening in the world, and I could kind of make my own conclusions, based on the fact that I couldn’t really hear what was happening. And that was because the noise in my head was too loud.
But now, life is good. Spending 35-plus years suicidal was something I don’t wish on anyone, and after six months in that study, I am not suicidal. I want to live.
My dad died in 1995, and it really wasn’t until session three of the MDMA trial where I really believed he was dead. So I don’t live in fear anymore.